• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声作为二线检测在卵巢癌筛查中对血清 CA125 的性能评估。

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

机构信息

Gynaecology Cancer Research Unit, St Bartholomew's Hospital, The Royal Hospitals NHS Trust, London.

出版信息

BJOG. 2014 Dec;121 Suppl 7:35-9. doi: 10.1111/1471-0528.13211.

DOI:10.1111/1471-0528.13211
PMID:25488086
Abstract

OBJECTIVE

To assess the performance of ultrasonography in a multimodal ovarian cancer screening strategy.

DESIGN

Prospective ovarian cancer screening trial between December 1986 and June 1993.

SETTING

General practice, occupational health departments and an ovarian cancer screening clinic at a London teaching hospital.

POPULATION

Postmenopausal women, ≥ 45 years with a raised CA125.

METHODS

Volunteers with a CA125 ≥ 30 U/mL underwent a pelvic ultrasound. Scans were classified as normal, abnormal (ovarian volume ≥ 8.8 mL) or equivocal (normal volume with abnormal morphology). Abnormal ovarian morphology was subclassified as simple cyst (single, thin walled cyst with no septa or papillary projections) or complex (all other abnormalities). Volunteers with abnormal scans were referred for a gynaecological opinion. Follow up was via the cancer registry and postal questionnaires.

MAIN OUTCOME MEASURES

Sensitivity, specificity and positive predictive value of different ultrasound criteria for detection of index cancer (e.g. primary invasive epithelial carcinoma of the ovary and fallopian tube).

RESULTS

Seven hundred and forty-one women underwent 1219 scans and 20 index cancers occurred during a median follow up of 6.8 years. The sensitivity for detection of ovarian cancer of different ultrasound criteria was 100% for abnormal morphology, 89.5% for abnormal volume and 84% for complex morphology. The highest specificity (97%) and positive predictive value (37.2%) was achieved using complex morphology.

CONCLUSION

A variety of ultrasound criteria can achieve high sensitivity, specificity and positive predictive value for index cancers in postmenopausal women with an elevated CA125. Use of ovarian morphology to interpret ultrasound may increase sensitivity and use of complex ovarian morphology may increase the positive predictive value.

摘要

目的

评估超声在多模式卵巢癌筛查策略中的表现。

设计

1986 年 12 月至 1993 年 6 月进行的前瞻性卵巢癌筛查试验。

地点

普通诊所、职业健康部门和伦敦教学医院的卵巢癌筛查诊所。

人群

绝经后妇女,年龄≥45 岁,CA125 升高。

方法

CA125≥30U/ml 的志愿者进行盆腔超声检查。扫描结果分为正常、异常(卵巢体积≥8.8ml)或不确定(体积正常但形态异常)。异常卵巢形态分为单纯囊肿(单个、薄壁囊肿,无隔膜或乳头状突起)或复杂(所有其他异常)。异常扫描的志愿者被转诊妇科意见。随访通过癌症登记处和邮寄问卷进行。

主要观察指标

不同超声标准对检测指数癌(如原发性上皮性卵巢癌和输卵管癌)的敏感性、特异性和阳性预测值。

结果

741 名妇女接受了 1219 次扫描,中位数随访 6.8 年后发生 20 例指数癌。不同超声标准检测卵巢癌的敏感性分别为异常形态 100%、异常体积 89.5%和复杂形态 84%。特异性最高(97%)和阳性预测值(37.2%)采用复杂形态。

结论

在 CA125 升高的绝经后妇女中,多种超声标准可实现对指数癌的高敏感性、特异性和阳性预测值。使用卵巢形态学解释超声可能会提高敏感性,使用复杂的卵巢形态学可能会提高阳性预测值。

相似文献

1
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.超声作为二线检测在卵巢癌筛查中对血清 CA125 的性能评估。
BJOG. 2014 Dec;121 Suppl 7:35-9. doi: 10.1111/1471-0528.13211.
2
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.超声作为卵巢癌筛查中血清CA125的二线检测方法的性能。
BJOG. 2000 Feb;107(2):165-9. doi: 10.1111/j.1471-0528.2000.tb11685.x.
3
Screening postmenopausal women for ovarian cancer: a systematic review.绝经后女性卵巢癌筛查:一项系统综述
J Obstet Gynaecol Can. 2004 Aug;26(8):717-28. doi: 10.1016/s1701-2163(16)30643-0.
4
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.使用 CA125 进行高度准确的卵巢癌检测,但血清基质辅助激光解吸电离飞行时间质谱分析谱图的改善有限。
Int J Gynecol Cancer. 2010 Dec;20(9):1518-24.
5
Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125.在化疗期间及随访过程中,通过血清肿瘤标志物CA125对卵巢癌患者进行监测。
Dan Med J. 2018 Apr;65(4).
6
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
7
Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.绝经状态、超声和生物标志物联合检测在有症状女性中的卵巢癌诊断。
Cochrane Database Syst Rev. 2022 Jul 26;7(7):CD011964. doi: 10.1002/14651858.CD011964.pub2.
8
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.癌症生物标志物在上皮性卵巢癌中的临床应用:欧洲肿瘤标志物小组的更新指南
Int J Gynecol Cancer. 2016 Jan;26(1):43-51. doi: 10.1097/IGC.0000000000000586.
9
Combination of the non-invasive tests for the diagnosis of endometriosis.用于诊断子宫内膜异位症的非侵入性检查组合
Cochrane Database Syst Rev. 2016 Jul 13;7(7):CD012281. doi: 10.1002/14651858.CD012281.
10
Integrating O-RADS US v2022, CEUS, and CA125 to enhance the diagnostic differentiation of ovarian masses: development of the OCC-US model.整合O-RADS US v2022、超声造影(CEUS)和CA125以提高卵巢肿块的诊断鉴别能力:OCC-US模型的开发
Cancer Imaging. 2025 Jul 30;25(1):96. doi: 10.1186/s40644-025-00918-5.

引用本文的文献

1
The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression activation of the Wnt/β-catenin signaling pathway.ARPC1B 的过表达促进卵巢癌细胞进展并激活 Wnt/β-catenin 信号通路。
Front Immunol. 2023 May 25;14:1182677. doi: 10.3389/fimmu.2023.1182677. eCollection 2023.
2
Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer.经阴道彩色多普勒超声(TV-CDS)联合血清肿瘤标志物在卵巢癌诊断中的临床价值
Oncol Lett. 2020 Aug;20(2):2028-2034. doi: 10.3892/ol.2020.11705. Epub 2020 Jun 5.
3
Role of Sonographic Gray-Scale Pattern Recognition in the Diagnosis of Adnexal Masses.
超声灰阶模式识别在附件包块诊断中的作用
J Clin Diagn Res. 2017 Sep;11(9):QC12-QC15. doi: 10.7860/JCDR/2017/28533.10614. Epub 2017 Sep 1.
4
The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.微小RNA 106b~25簇血浆表达升高在胃癌中的意义
PLoS One. 2017 May 31;12(5):e0178427. doi: 10.1371/journal.pone.0178427. eCollection 2017.
5
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.应用卵巢癌风险算法和频繁 CA125 检测对家族性卵巢癌风险升高的女性进行卵巢癌早期检测:两项筛查试验的联合结果。
Clin Cancer Res. 2017 Jul 15;23(14):3628-3637. doi: 10.1158/1078-0432.CCR-15-2750. Epub 2017 Jan 31.
6
Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.基于血浆氨基酸谱的指标与CA125在诊断上皮性卵巢癌及交界性恶性肿瘤中的比较
Int J Clin Oncol. 2017 Feb;22(1):118-125. doi: 10.1007/s10147-016-1035-4. Epub 2016 Sep 13.